These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3899154)

  • 1. The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach.
    Sartorelli AC
    Br J Cancer; 1985 Sep; 52(3):293-302. PubMed ID: 3899154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms involved in the induction of malignant cell differentiation.
    Sartorelli AC; Ishiguro K; King CL; Morin MJ; Reiss M
    Adv Enzyme Regul; 1986; 25():507-29. PubMed ID: 3544708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of leukemia cell differentiation by chemotherapeutic agents.
    Schwartz EL; Ishiguro K; Sartorelli AC
    Adv Enzyme Regul; 1983; 21():3-20. PubMed ID: 6400065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
    Schwartz EL; Sartorelli AC
    Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
    Frank DA; Sartorelli AC
    Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin.
    Morin MJ; Sartorelli AC
    Cancer Res; 1984 Jul; 44(7):2807-12. PubMed ID: 6327026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the differentiation-inducing properties of 6-thioguanine by hypoxanthine and its nucleosides in HL-60 promyelocytic leukemia cells.
    Ishiguro K; Sartorelli AC
    Cancer Res; 1985 Jan; 45(1):91-5. PubMed ID: 3855287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
    Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC
    Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells.
    Ishiguro K; Schwartz EL; Sartorelli AC
    J Cell Physiol; 1984 Nov; 121(2):383-90. PubMed ID: 6593322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells.
    Gianni M; Fratelli M; Bolis M; Kurosaki M; Zanetti A; Paroni G; Rambaldi A; Borleri G; Rochette-Egly C; Terao M; Garattini E
    Oncotarget; 2017 Jun; 8(23):37041-37060. PubMed ID: 27419624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of erythroid differentiation by the anthracycline antitumor antibiotics, aclacinomycin A, musettamycin and marcellomycin.
    Steinheider G; Westendorf J; Marquardt H
    Leuk Res; 1986; 10(10):1233-9. PubMed ID: 3464812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
    Schwartz EL; Blair OC; Sartorelli AC
    Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of 6-thioguanine activity by guanine in human promyelocytic leukemia HL-60 cells.
    Cheng HW; Armstrong RD; Sadée W
    Cancer Res; 1988 Jul; 48(13):3648-51. PubMed ID: 3163939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance in the nucleotide pools of myeloid leukemia cells and HL-60 cells: correlation with cell-cycle phase, proliferation, differentiation, and transformation.
    de Korte D; Haverkort WA; de Boer M; van Gennip AH; Roos D
    Cancer Res; 1987 Apr; 47(7):1841-7. PubMed ID: 3469022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine.
    Zimm S; Johnson GE; Poplack DG
    Cancer Res; 1986 Dec; 46(12 Pt 1):6286-9. PubMed ID: 3465436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.
    Breitman TR; Selonick SE; Collins SJ
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2936-40. PubMed ID: 6930676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of WEHI-3B D+ monomyelocytic leukemia cells by retinoic acid and aclacinomycin A.
    Gamba-Vitalo C; Blair OC; Keyes SR; Sartorelli AC
    Cancer Res; 1986 Mar; 46(3):1189-94. PubMed ID: 3455881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of cancer chemotherapeutic agents on induction of differentiation of cells and their therapeutic implications].
    Hozumi M
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):714-20. PubMed ID: 3457551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of the terminal differentiation of a human squamous cell carcinoma by steroids with glucocorticoid activity.
    Violette SM; King I; Sartorelli AC
    J Steroid Biochem; 1989 Nov; 33(5):1001-5. PubMed ID: 2481155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
    Prus E; Fibach E
    Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.